Roopa Industries Ltd vs Samrat Pharmachem Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Roopa Industries Ltd is ₹ 56.6 as of 04 May 10:31 . The P/E Ratio of Roopa Industries Ltd changed from 10.3 on March 2021 to 19.8 on March 2025 . This represents a CAGR of 13.96% over 5 yearsThe P/E Ratio of Samrat Pharmachem Ltd changed from 7.9 on March 2021 to 13.6 on March 2025 . This represents a CAGR of 11.48% over 5 years The Market Cap of Roopa Industries Ltd changed from ₹ 7.36 crore on March 2021 to ₹ 40.25 crore on March 2025 . This represents a CAGR of 40.47% over 5 yearsThe Market Cap of Samrat Pharmachem Ltd changed from ₹ 42.02 crore on March 2021 to ₹ 96.63 crore on March 2025 . This represents a CAGR of 18.12% over 5 years The revenue of Roopa Industries Ltd for the Dec '25 is ₹ 33.54 crore as compare to the Sep '25 revenue of ₹ 28.75 crore. This represent the growth of 16.66% The revenue of Samrat Pharmachem Ltd for the Dec '25 is ₹ 63.83 crore as compare to the Sep '25 revenue of ₹ 78.92 crore. This represent the decline of -19.12% The ebitda of Roopa Industries Ltd for the Dec '25 is ₹ 2.03 crore as compare to the Sep '25 ebitda of ₹ 1.64 crore. This represent the growth of 23.78% The ebitda of Samrat Pharmachem Ltd for the Dec '25 is ₹ -0.26 crore as compare to the Sep '25 ebitda of ₹ -0.31 crore. This represent the decline of -16.13% The net profit of Roopa Industries Ltd changed from ₹ 0.27 crore to ₹ 0.77 crore over 7 quarters. This represents a CAGR of 82.00% The net profit of Samrat Pharmachem Ltd changed from ₹ 2.07 crore to ₹ -0.46 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Roopa Industries Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Samrat Pharmachem Ltd changed from 1.8 % on March 2022 to 4.35 % on March 2025 . This represents a CAGR of 24.68% over 4 years .

About Roopa Industries Ltd

Roopa Industries Limited is a part of the TGV Group, a reputed conglomerate in India, which manufactures and exports Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids and Water Treatment Chemicals to various countries.
The Company was incorporated in 1985 and operates into manufacturing and marketing of bulk drugs and intermediaries.
The Company became a manufacturer of Neutraceuticals, Fine chemicals, Drug Intermediates and Bulk Drugs since 1998.
Over the years, it has been a principal supplier to many companies in various countries. The Company handled critical and risky processes and have dependable technical expertise for carrying out any labyrinthine hazardous manufacturing operations.
It offers triphenyl phosphine for use as wittig reagent in the manufacture of pharmaceuticals and cosmetics; as catalyst in hydroformylation, isomerisation, and polymerisation of olefins; as catalysing and curing agent in a range of polymerization reactions, epoxy resins, and photopolymers; and as reducing and deoxygenating agent in quinones, epoxides, amine oxides, and sulfoxides.

About Samrat Pharmachem Ltd

Samrat Pharmachem Limited was incorporated on June 16, 1992 at Ankleshwar in Gujarat led by the Promoters, Mr. Lalit Mehta & Mr. Rajesh Mehta.
Since then, it envisioned to focus on lodine Derivatives as their core products.
The Company's principal activities are manufacturing and selling chemicals.
Company is a producer of pharmaceutical chemicals.
The intermediates produced are used in pharmaceutical and chemical industries.

FAQs for the comparison of Roopa Industries Ltd and Samrat Pharmachem Ltd

Which company has a larger market capitalization, Roopa Industries Ltd or Samrat Pharmachem Ltd?

Market cap of Roopa Industries Ltd is 47 Cr while Market cap of Samrat Pharmachem Ltd is 65 Cr

What are the key factors driving the stock performance of Roopa Industries Ltd and Samrat Pharmachem Ltd?

The stock performance of Roopa Industries Ltd and Samrat Pharmachem Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Roopa Industries Ltd and Samrat Pharmachem Ltd?

As of May 4, 2026, the Roopa Industries Ltd stock price is INR ₹60.48. On the other hand, Samrat Pharmachem Ltd stock price is INR ₹211.1.

How do dividend payouts of Roopa Industries Ltd and Samrat Pharmachem Ltd compare?

To compare the dividend payouts of Roopa Industries Ltd and Samrat Pharmachem Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.